{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:43:35Z","timestamp":1785876215801,"version":"3.56.0"},"reference-count":53,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Chronic spontaneous urticaria (CSU) is a common inflammatory skin disease characterized by severe itching and wheals, affecting approximately 1.4% of the global population. Both second-generation H1-antihistamines and omalizumab have limited efficacy in some patients. Previous studies suggest that combining traditional Chinese medicine with biological agents may improve efficacy and reduce adverse effects in inflammatory skin diseases.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n \n This study uses a trials within cohorts (TwiCs) design to evaluate the efficacy and safety of the\n shenqi<\/jats:italic>\n formula (SQF) combined with omalizumab for the treatment of CSU.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n This TwiCs study is built upon an existing urticaria cohort established in November 2019 at Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine. Overall, 92 eligible patients with type 1 autoallergic CSU and\n qi<\/jats:italic>\n and blood deficiency syndrome will be randomly allocated in a 1:1 ratio to receive either omalizumab alone or omalizumab combined with the SQF. The treatment period is 24 weeks, followed by 16 weeks of follow-up. The primary outcome is the 7-day Urticaria Activity Score. Data will be managed using Microsoft Excel (version 2016), analyzed with SPSS (version 27.0; IBM Corp), and visualized with GraphPad Prism (version 9.0). A complier average causal effect analysis will be applied to estimate causal effects using generalized linear latent mixed models.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n As of the manuscript submission (November 2025), the trial has been funded (December 2024) and registered with the International Traditional Medicine Clinical Trial Registry (registered January 28, 2025). Patient enrollment commenced in April 2025 and is projected to conclude by December 2027. Data analysis is expected to be completed by June 2028, with final results anticipated for publication in the fourth quarter of 2028.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n This study is the first to apply a TwiCs design to compare the efficacy and safety of SQF combined with omalizumab versus omalizumab alone in patients with CSU. The findings are expected to provide high-quality real-world evidence for the integration of traditional Chinese medicine with biological therapy in the management of CSU and to serve as a methodological reference for future TwiCs applications in dermatology research.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/88251","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:50:05Z","timestamp":1779810605000},"page":"e88251-e88251","source":"Crossref","is-referenced-by-count":0,"title":["Integrated Traditional Chinese and Western Medicine for Chronic Spontaneous Urticaria: Protocol for a Trials Within Cohorts Study"],"prefix":"10.2196","volume":"15","author":[{"given":"Linhao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"issue":"3","key":"R1","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA\u00b2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier","journal-title":"Allergy"},{"issue":"12","key":"R2","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.35541\/cjd.20220609","article-title":"Guideline for diagnosis and treatment of urticaria in China (2022) [Article in Chinese]","volume":"55","author":"Centre for Urticaria Research, Chinese Society of Dermatology","journal-title":"Chin J Dermatol"},{"issue":"8","key":"R3","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.jaip.2023.02.006","article-title":"Most patients with autoimmune chronic spontaneous urticaria also have autoallergic urticaria, but not vice versa","volume":"11","author":"Xiang","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"R4","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/j.jaci.2022.04.010","article-title":"Autoimmune chronic spontaneous urticaria","volume":"149","author":"Kolkhir","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"R5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/all.14037","article-title":"Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis","volume":"75","author":"Fricke","journal-title":"Allergy"},{"issue":"6","key":"R6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.35541\/cjd.20230004","article-title":"Expert consensus on treat-to-target in chronic spontaneous urticaria [Article in Chinese]","volume":"56","author":"Chinese Society of Dermatology, China Dermatologist Association","journal-title":"Chin J Dermatol"},{"issue":"2","key":"R7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/all.15603","article-title":"Chronic spontaneous urticaria: focus on pathophysiology to unlock treatment advances","volume":"78","author":"Kaplan","journal-title":"Allergy"},{"issue":"10","key":"R8","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJMoa1215372","article-title":"Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria","volume":"368","author":"Maurer","journal-title":"N Engl J Med"},{"issue":"1","key":"R9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/jamadermatol.2018.3447","article-title":"Benefits and harms of omalizumab treatment in adolescent and adult patients with chronic idiopathic (spontaneous) urticaria: a meta-analysis of \u201creal-world\u201d evidence","volume":"155","author":"Tharp","journal-title":"JAMA Dermatol"},{"issue":"11","key":"R10","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamadermatol.2021.3237","article-title":"Evaluation of pharmacologic treatments for H1 antihistamine-refractory chronic spontaneous urticaria: a systematic review and network meta-analysis","volume":"157","author":"Nochaiwong","journal-title":"JAMA Dermatol"},{"issue":"2","key":"R11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/bjd.13845","article-title":"Omalizumab in patients with chronic spontaneous urticaria: a systematic review and GRADE assessment","volume":"173","author":"Urgert","journal-title":"Br J Dermatol"},{"issue":"6","key":"R12","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1016\/j.jaci.2015.12.1342","article-title":"Omalizumab for the treatment of chronic spontaneous urticaria: a meta-analysis of randomized clinical trials","volume":"137","author":"Zhao","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"R13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037305","article-title":"Efficacy and safety of xiaofeng powder in the treatment of chronic urticaria: a systematic review and meta-analysis","volume":"103","author":"Bi","journal-title":"Medicine (Baltimore)"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1200252","article-title":"Efficacy and safety of runzao zhiyang capsule for chronic urticaria: a systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Zhang","journal-title":"Front Pharmacol"},{"issue":"2","key":"R15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.11817\/j.issn.1672-7347.2024.230381","article-title":"Clinical efficacy of zhiyang xiaozhen granules combined with second-generation antihistamine in the treatment of chronic urticaria [Article in English, Chinese]","volume":"49","author":"Zhang","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4012416","article-title":"Efficacy of fangfeng tongsheng granule combined with levocetirizine in the treatment of chronic urticaria and its effect on serum complement, IL-4, IgE, and IFN-\u03b3 levels in patients","volume":"2022","author":"Xu","journal-title":"Evid Based Complement Alternat Med"},{"key":"R17","unstructured":"Huang S . Real-world study on the treatment of psoriasis with traditional Chinese medicine combined with biologics [Master\u2019s thesis]. Beijing University of Chinese Medicine; 2023."},{"issue":"2","key":"R18","volume":"8","author":"Yang","journal-title":"World J Integr Tradit West Med"},{"issue":"5","key":"R19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.13422\/j.cnki.syfjx.20240995","article-title":"Randomized controlled trial design based on patient cohorts: methods and applications of trials within cohorts [Article in Chinese]","volume":"30","author":"Wang","journal-title":"Chin J Exp Tradit Med Formulae"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","journal-title":"BMJ"},{"issue":"3","key":"R21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials","volume":"158","author":"Chan","journal-title":"Ann Intern Med"},{"key":"R22","unstructured":"Li C Chen D . Integrated Traditional Chinese and Western Dermatology. Ronghe Publishing; 2023. ISBN: 9787513283472"},{"issue":"3","key":"R23","first-page":"274","volume":"16","author":"Dermatology Branch of the China Association of Chinese Medicine","journal-title":"Chin J Dermato Venerol Integ Trad W Med"},{"issue":"1","key":"R24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/jid.2014.306","article-title":"Efficacy and safety of omalizumab in patients with chronic idiopathic\/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study","volume":"135","author":"Saini","journal-title":"J Invest Dermatol"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2019.153076","article-title":"Huangqi-Fangfeng protects against allergic airway remodeling through inhibiting epithelial-mesenchymal transition process in mice via regulating epithelial derived TGF-\u03b21","volume":"64","author":"Yao","journal-title":"Phytomedicine"},{"issue":"12","key":"R26","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.35541\/cjd.20210568","article-title":"Consensus on management of chronic urticaria using anti-immunoglobulin E therapy (omalizumab) [Article in Chinese]","volume":"54","author":"Centre for Urticaria Research, Chinese Society of Dermatology","journal-title":"Chin J Dermatol"},{"issue":"1","key":"R27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/all.13271","article-title":"Comparison and interpretability of the available urticaria activity scores","volume":"73","author":"Hawro","journal-title":"Allergy"},{"issue":"4","key":"R28","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/bjd.15454","article-title":"Analysis of disease activity categories in chronic spontaneous\/idiopathic urticaria","volume":"177","author":"Stull","journal-title":"Br J Dermatol"},{"issue":"5","key":"R29","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.jaci.2013.12.1076","article-title":"Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control","volume":"133","author":"Weller","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"R30","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.jaci.2017.04.050","article-title":"Responsiveness and minimal important difference of the urticaria control test","volume":"140","author":"Ohanyan","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"R31","first-page":"80","volume":"24","author":"J\u00e1uregui","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R32","unstructured":"Zhang C . Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL): adaptation and initial results among Chinese patients [Master\u2019s thesis]. Central South University; 2014."},{"issue":"8","key":"R33","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/j.1398-9995.2005.00833.x","article-title":"A new tool to evaluate the impact of chronic urticaria on quality of life: Chronic Urticaria Quality of Life Questionnaire (CU-QoL)","volume":"60","author":"Baiardini","journal-title":"Allergy"},{"key":"R34","unstructured":"Zheng XY . Guiding Principles for Clinical Research of New Chinese Medicine (Trial) [Book in Chinese]. China Medical Science and Technology Press; 2002."},{"key":"R35","unstructured":"Hu DY . Clinical observation on the therapeutic effect of catgut embedding with the method of supplementing qi and nourishing blood on chronic spontaneous urticaria with deficiency of qi and blood [master\u2019s thesis]. Fujian University of Traditional Chinese Medicine; 2023."},{"issue":"4","key":"R36","first-page":"620","volume":"32","author":"Chen","journal-title":"Chin J Health Stat"},{"issue":"3","key":"R37","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jaip.2019.10.046","article-title":"Sexual functioning is frequently and markedly impaired in female patients with chronic spontaneous urticaria","volume":"8","author":"Erta\u015f","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"R38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1046\/j.1365-2133.1997.d01-1168.x","article-title":"The impact of chronic urticaria on the quality of life","volume":"136","author":"O\u2019Donnell","journal-title":"Br J Dermatol"},{"issue":"1","key":"R39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41572-022-00389-z","article-title":"Urticaria","volume":"8","author":"Kolkhir","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"R40","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1111\/all.13209","article-title":"The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU","volume":"72","author":"Maurer","journal-title":"Allergy"},{"issue":"2","key":"R41","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/bjd.19561","article-title":"The global burden of chronic urticaria for the patient and society","volume":"184","author":"Gon\u00e7alo","journal-title":"Br J Dermatol"},{"issue":"1","key":"R42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12016-020-08794-6","article-title":"Omalizumab updosing in chronic spontaneous urticaria: an overview of real-world evidence","volume":"59","author":"Metz","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"R43","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12010378","article-title":"IgG and IgE autoantibodies to IgE receptors in chronic spontaneous urticaria and their role in the response to omalizumab","volume":"12","author":"Maronese","journal-title":"J Clin Med"},{"issue":"11","key":"R44","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1016\/j.jaip.2021.07.043","article-title":"Autoimmune chronic spontaneous urticaria detection with IgG anti-TPO and total IgE","volume":"9","author":"Kolkhir","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"R45","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/all.13345","article-title":"The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change","volume":"73","author":"Ertas","journal-title":"Allergy"},{"issue":"4","key":"R46","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.jaip.2017.10.030","article-title":"Serum IgE as an immunological marker to predict response to omalizumab treatment in symptomatic chronic urticaria","volume":"6","author":"Straesser","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"R47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jaci.2013.05.013","article-title":"Omalizumab in patients with symptomatic chronic idiopathic\/spontaneous urticaria despite standard combination therapy","volume":"132","author":"Kaplan","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"R48","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1142\/S0192415X23500374","article-title":"Traditional Chinese herbal medicine for allergic diseases: a review","volume":"51","author":"Ai","journal-title":"Am J Chin Med"},{"issue":"1","key":"R49","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/imr.13380","article-title":"Therapeutic monoclonal antibodies in allergy: targeting IgE, cytokine, and alarmin pathways","volume":"328","author":"Eggel","journal-title":"Immunol Rev"},{"issue":"7","key":"R50","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1007\/s00403-023-02575-9","article-title":"Discovery of a traditional Chinese herbal combination for the treatment of atopic dermatitis: saposhnikoviae radix, astragali radix and cnidium monnieri","volume":"315","author":"Ren","journal-title":"Arch Dermatol Res"},{"issue":"22","key":"R51","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1097\/00029330-200611020-00008","volume":"119","author":"Gan","journal-title":"Chin Med J (Engl)"},{"key":"R52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2018.04.015","article-title":"Tanshinone IIA suppresses Fc\u03b5RI-mediated mast cell signaling and anaphylaxis by activation of the Sirt1\/LKB1\/AMPK pathway","volume":"152","author":"Li","journal-title":"Biochem Pharmacol"},{"key":"R53","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c1066","article-title":"Rethinking pragmatic randomised controlled trials: introducing the \u201ccohort multiple randomised controlled trial\u201d design","volume":"340","author":"Relton","journal-title":"BMJ"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:43:40Z","timestamp":1785872620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e88251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":53,"URL":"https:\/\/doi.org\/10.2196\/88251","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"article-number":"v15i3e88251"}}